|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06887 SUNSHINE PHARMA
Nominal 
() Profitability Analysis
| 2024/12 | 2023/12 | 2022/12 | |
| ROAA (%) | -1.687% | 1.584% | -10.147% |
| ROAE (%) | -61.730% | N/A | 29.404% |
| Return on Capital Employed (%) | -2.915% | 2.854% | -62.671% |
Margin Analysis
| 2024/12 | 2023/12 | 2022/12 | |
| Gross Profit Margin (%) | 76.106% | 79.508% | 76.626% |
| EBITDA Margin (%) | 18.321% | 32.841% | -11.724% |
| Pre-tax Profit Margin (%) | 3.510% | 21.697% | -38.804% |
| Net Profit Margin (%) | -5.161% | 2.896% | -28.441% |
Liquidity Analysis
| 2024/12 | 2023/12 | 2022/12 | |
| Current Ratio (X) | 1.034 X | 1.038 X | 0.463 X |
| Quick Ratio (X) | 0.881 X | 0.952 X | 0.422 X |
Leverage Analysis
| 2024/12 | 2023/12 | 2022/12 | |
| Total Liabilities / Total Assets(%) | 62.557% | 67.015% | 108.176% |
| Total Debt / Total Assets (%) | 38.756% | 42.272% | 58.756% |
| Net Debt / Total Assets (%) | 26.345% | 27.102% | 49.667% |
| Total Debt / Shareholders' Funds (%) | 1343.657% | 1631.732% | N/A |
| Long Term Debt / Shareholders' Funds (%) | 693.539% | 619.018% | N/A |
| Net Debt / Shareholders' Funds (%) | 913.375% | 1046.177% | N/A |
| Net Cash / (Debt) ($) | (3.143B) | (3.431B) | (5.309B) |
| Net Cash / (Debt) per share ($) | (5.451) | (5.949) | (9.206) |
| Total Debt / Capital Employed (%) | 64.971% | 82.579% | 362.890% |
| Interest Coverage Ratio (X) | 1.588 X | 4.640 X | N/A |
Efficiency Analysis
| 2024/12 | 2023/12 | 2022/12 | |
| Inventory Turnover (Day) | 240.755 Day | 124.885 Day | 150.063 Day |
| Receivables Turnover (Day) | 164.792 Day | 77.595 Day | 77.397 Day |
| Payables Turnover (Day) | 98.778 Day | 45.417 Day | 71.283 Day |
| Remarks: | Real time quote last updated: 18/07/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -207,434 |
| %Change | -- |
| EPS / (LPS) | RMB -0.470 |
| NBV Per Share (¥) | RMB 0.597 |